HIM
WST icon

Hermes Investment Management’s West Pharmaceutical WST Stock Holding History

Hermes Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$96.2M Buy
968,945
+44,169
+5% +$4.07M 1.28% 10
2018
Q1 		$81.6M Sell
924,776
-14,575
-2% -$1.36M 1.19% 12
2017
Q4 		$92.7M Buy
939,351
+30,696
+3% +$3.01M 1.33% 11
2017
Q3 		$87.5M Buy
908,655
+28,955
+3% +$2.62M 1.31% 11
2017
Q2 		$83.1M Sell
879,700
-70,101
-7% -$6.45M 1.35% 11
2017
Q1 		$77.5M Buy
949,801
+7,628
+0.8% +$638K 1.25% 19
2016
Q4 		$79.9M Sell
942,173
-165,676
-15% -$13M 1.37% 12
2016
Q3 		$82.5M Buy
1,107,849
+28,982
+3% +$2.3M 1.4% 10
2016
Q2 		$81.9M Buy
1,078,867
+150,064
+16% +$10.9M 1.65% 7
2016
Q1 		$65.5M Sell
928,803
-81,612
-8% -$4.91M 1.37% 12
2015
Q4 		$60.8M Buy
1,010,415
+65,155
+7% +$3.92M 1.38% 17
2015
Q3 		$51.2M Buy
945,260
+127,020
+16% +$7.4M 1.32% 16
2015
Q2 		$47.5M Buy
818,240
+32,650
+4% +$1.82M 1.07% 21
2015
Q1 		$47.3M Buy
785,590
+189,997
+32% +$10.1M 1.1% 19
2014
Q4 		$31.7M Buy
595,593
+4,837
+0.8% +$242K 0.82% 36
2014
Q3 		$26.4M Buy
590,756
+566,756
+2,361% +$24.1M 0.68% 69
2014
Q2 		$1.01M Hold
24,000
– – 0.03% 172
2014
Q1 		$1.06M Sell
24,000
-97,620
-80% -$4.6M 0.03% 167
2013
Q4 		$5.97M Hold
121,620
– – 0.18% 91
2013
Q3 		$5M Sell
121,620
-747,194
-86% -$28.5M 0.17% 92
2013
Q2 		$30.5M Buy
+868,814
New +$28.6M 1.19% 34

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Hermes Investment Management's WST Position: Q2 2018 in Review

Hermes Investment Management increased its West Pharmaceutical (WST) stake by 4.8% in Q2 2018, buying an estimated $4.07M and bringing the position to 968,945 shares worth $96.2M. The position accounts for 1.28% of the portfolio, ranked #10.

Hermes Investment Management first reported a position in WST in Q2 2013 and has held it in 21 quarters since. 323 funds tracked by Wall St. Rank hold WST as of Q2 2018.

  • Hermes Investment Management held 968,945 shares of West Pharmaceutical worth $96.2M as of Q2 2018.
  • Hermes Investment Management bought 44,169 West Pharmaceutical shares in Q2 2018, an estimated $4.07M.
  • West Pharmaceutical made up 1.28% of Hermes Investment Management's portfolio in Q2 2018, its #10 holding.
  • Hermes Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 21 quarters since.
  • 323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.